NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
NeuroPace Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$12.77+0.53 (+4.33%)
Close on Oct 19, 2026
- Market cap
- $435.51M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
77.4%
27M of 34M shares
Institutional holders
113
19 new, 18 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $399.25K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Mathew P. Arens | 4,203,931 | 12.25% | 13G (passive) amendment | Aug 31, 2026 |
| Polar Capital LLP | 2,972,003 | 9.13% | 13G (passive) | Mar 31, 2025 |
| Guy Levy | 2,957,957 | 8.90% | 13G (passive) amendment | Sep 30, 2025 |
| Morgan Stanley | 2,489,391 | 8.30% | 13G (passive) amendment | Dec 31, 2024 |
| OrbiMed Capital GP VI LLC | 2,096,527 | 6.20% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NPCE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 3,298,104 | 9.61% | $52.41M | – | 0.12% |
| Soleus Capital Management, L.P. | 2,911,122 | 8.48% | $46.26M | −21,085 | 1.59% |
| First Light Asset Management, LLC | 2,861,167 | 8.34% | $45.46M | +401,201 | 2.76% |
| Morgan Stanley | 2,654,391 | 7.73% | $42.18M | +87,552 | 0.00% |
| BlackRock, Inc. | 2,477,603 | 7.22% | $39.37M | +131,270 | 0.00% |
| Orbimed Advisors LLC | 1,505,125 | 4.39% | $23.92M | −591,402 | 0.44% |
| Driehaus Capital Management LLC | 1,447,391 | 4.22% | $23.00M | −4,220 | 0.13% |
| Vanguard Capital Management LLC | 1,227,072 | 3.57% | $19.50M | +103,361 | 0.00% |
| Deutsche Bank AG\ | 938,919 | 2.74% | $14.92M | +6,829 | 0.00% |
| Armistice Capital, LLC | 692,000 | 2.02% | $11.00M | – | 0.13% |
| Geode Capital Management, LLC | 666,300 | 1.94% | $10.59M | +48,181 | 0.00% |
| FMR LLC | 554,771 | 1.62% | $8.82M | +1,242 | 0.00% |
| State Street Corp | 550,132 | 1.60% | $8.74M | +52,586 | 0.00% |
| Silvercrest Asset Management Group LLC | 344,124 | 1.00% | $5.47M | −15,941 | 0.04% |
| Northern Trust Corp | 260,025 | 0.76% | $4.13M | +20,185 | 0.00% |
| Qube Research & Technologies Ltd | 221,237 | 0.64% | $3.52M | +35,048 | 0.00% |
| Vanguard Portfolio Management LLC | 220,371 | 0.64% | $3.50M | +32,942 | 0.00% |
| Palumbo Wealth Management LLC | 209,199 | 0.61% | $3.32M | −1,270 | 0.70% |
| Essex Investment Management Co LLC | 208,703 | 0.61% | $3.32M | −9,035 | 0.43% |
| Algert Global LLC | 184,774 | 0.54% | $2.94M | +5,218 | 0.03% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 113 | 27M | 77.4% | 19 / 48 | 36 / 18 | 2M | 1M |
| Q1 2026 | 113 | 26M | 77.1% | 28 / 39 | 36 / 13 | 4M | 2M |
| Q4 2025 | 100 | 26M | 76.7% | 26 / 38 | 29 / 4 | 3M | 2M |
| Q3 2025 | 80 | 26M | 75.6% | 10 / 34 | 20 / 28 | 5M | 2M |
| Q2 2025 | 98 | 23M | 65.6% | 21 / 46 | 23 / 13 | 4M | 6M |
| Q1 2025 | 90 | 24M | 69.7% | 35 / 28 | 15 / 6 | 10M | 7M |
| Q4 2024 | 62 | 21M | 60.8% | 18 / 21 | 10 / 4 | 6M | 0M |
| Q3 2024 | 48 | 15M | 43.1% | 8 / 16 | 14 / 9 | 3M | 1M |
| Q2 2024 | 51 | 15M | 43.9% | 18 / 17 | 13 / 21 | 3M | 7M |
| Q1 2024 | 54 | 18M | 53.5% | 18 / 20 | 12 / 5 | 4M | 2M |
| Q4 2023 | 41 | 16M | 47.6% | 18 / 15 | 7 / 1 | 4M | 0M |
| Q3 2023 | 25 | 18M | 52.7% | 5 / 10 | 5 / 1 | 2M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NPCE | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 908,479 | 2.65% | $14.44M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 688,652 | 2.01% | $10.94M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 290,400 | 0.85% | $4.61M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 288,065 | 0.84% | $3.71M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 248,901 | 0.73% | $3.96M | 0.03% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund | 227,093 | 0.66% | $3.76M | 0.07% | May 29, 2026 |
| Fidelity Small Cap Growth Fund | 209,986 | 0.61% | $2.71M | 0.03% | Jul 31, 2026 |
| Driehaus Micro Cap Growth Fund | 175,099 | 0.51% | $2.78M | 0.47% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 131,045 | 0.38% | $2.17M | 0.01% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 126,017 | 0.37% | $2.08M | 0.00% | May 31, 2026 |
| Fidelity Small Cap Growth K6 Fund | 108,032 | 0.31% | $1.39M | 0.03% | Jul 31, 2026 |
| North Square Dynamic Small Cap Fund | 91,663 | 0.27% | $1.52M | 0.19% | May 31, 2026 |
| iShares Micro-Cap ETF | 89,094 | 0.26% | $1.42M | 0.09% | Jun 30, 2026 |
| Adara Smaller Companies Fund | 85,121 | 0.25% | $1.41M | 0.17% | May 31, 2026 |
| Schwab Small-Cap Index Fund | 64,471 | 0.19% | $831.03K | 0.01% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joel Becker | CHIEF EXECUTIVE OFFICER, Director | 138,000 | 0.40% | Sep 4, 2026 |
| Martha Morrell | CHIEF MEDICAL OFFICER | 51,357 | 0.15% | Sep 25, 2026 |
| Patrick F. Williams | Chief Financial Officer | 67,508 | 0.20% | Sep 21, 2026 |
| Rebecca Kuhn | CHIEF FINANCIAL OFFICER | 131,613 | 0.38% | Jun 6, 2025 |
| Uri Geiger | Director | 4,451,485 | 12.97% | Jun 22, 2026 |
| Rakhi Kumar | Director | 23,039 | 0.07% | Jun 22, 2026 |
| Frank M. Fischer | Director | 599,534 | 1.75% | Jun 22, 2026 |
| R. Scott Huennekens | Director | 2,890 | 0.01% | Jun 5, 2026 |
| Renee Ryan | Director | 2,890 | 0.01% | Jun 5, 2026 |
| Lisa Andrade | Director | 2,890 | 0.01% | Jun 5, 2026 |
| Joseph Lacob | Director | 238,308 | 0.69% | Mar 24, 2026 |
| Advisors Llc Orbimed | 10% owner | 3,272,199 | 9.53% | May 16, 2025 |
| Capital GP VI LLC OrbiMed | 10% owner | 3,501,975 | 10.20% | May 16, 2025 |
| Ltd. Kck | 10% owner | 0 | – | Feb 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Martha Morrell CHIEF MEDICAL OFFICER | Sep 24, 2026 | Tax withholding | −335 | $13.97 | $4.68K | 51,357 |
| Patrick F. Williams Chief Financial Officer | Sep 20, 2026 | Tax withholding | −1,162 | $14.28 | $16.59K | 67,508 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Sep 3, 2026 | Tax withholding | −1,310 | $14.75 | $19.32K | 138,000 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Aug 27, 2026 | Tax withholding | −1,126 | $14.13 | $15.91K | 139,310 |
| Martha Morrell CHIEF MEDICAL OFFICER | Aug 27, 2026 | Tax withholding | −358 | $14.13 | $5.06K | 51,692 |
| Martha Morrell CHIEF MEDICAL OFFICER | Jun 24, 2026 | Tax withholding | −335 | $16.22 | $5.43K | 52,050 |
| Rakhi Kumar Director | Jun 19, 2026 | Award | +989 | $15.63 | $15.46K | 23,039 |
| Frank M. Fischer Director | Jun 19, 2026 | Award | +1,467 | $15.63 | $22.93K | 599,534 |
| Uri Geiger Director | Jun 19, 2026 | Award | +789 | $15.63 | $12.33K | 18,537 |
| Frank M. Fischer Director | Jun 5, 2026 | Award | +2,890 | – | – | 598,067 |
| Lisa Andrade Director | Jun 5, 2026 | Award | +2,890 | – | – | 2,890 |
| Uri Geiger Director | Jun 5, 2026 | Award | +2,890 | – | – | 17,748 |
| Rakhi Kumar Director | Jun 5, 2026 | Award | +2,890 | – | – | 22,050 |
| R. Scott Huennekens Director | Jun 5, 2026 | Award | +2,890 | – | – | 2,890 |
| Renee Ryan Director | Jun 5, 2026 | Award | +2,890 | – | – | 2,890 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Jun 3, 2026 | Tax withholding | −1,255 | $15.88 | $19.93K | 140,436 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | May 27, 2026 | Tax withholding | −1,126 | $17.06 | $19.21K | 141,691 |
| Martha Morrell CHIEF MEDICAL OFFICER | May 27, 2026 | Tax withholding | −358 | $17.06 | $6.11K | 52,385 |
| Martha Morrell CHIEF MEDICAL OFFICER | May 15, 2026 | Award | +5,460 | – | – | 52,743 |
| Patrick F. Williams Chief Financial Officer | May 15, 2026 | Award | +16,820 | – | – | 68,670 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | May 15, 2026 | Award | +45,880 | – | – | 142,817 |
| Martha Morrell CHIEF MEDICAL OFFICER | Mar 24, 2026 | Tax withholding | −1,341 | $13.27 | $17.80K | 47,283 |
| Joseph Lacob Director | Mar 20, 2026 | Award | +865 | $13.00 | $11.25K | 14,754 |
| Uri Geiger Director | Mar 20, 2026 | Award | +913 | $13.00 | $11.87K | 14,858 |
| Frank M. Fischer Director | Mar 20, 2026 | Award | +1,826 | $13.00 | $23.74K | 595,177 |
| Rakhi Kumar Director | Mar 20, 2026 | Award | +1,153 | $13.00 | $14.99K | 19,160 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Mar 3, 2026 | Tax withholding | −5,023 | $13.83 | $69.47K | 96,937 |
| Martha Morrell CHIEF MEDICAL OFFICER | Mar 3, 2026 | Tax withholding | −1,340 | $13.83 | $18.53K | 48,624 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Feb 27, 2026 | Tax withholding | −1,126 | $14.58 | $16.42K | 101,960 |
| Martha Morrell CHIEF MEDICAL OFFICER | Feb 27, 2026 | Tax withholding | −358 | $14.58 | $5.22K | 74,964 |
| Martha Morrell CHIEF MEDICAL OFFICER | Feb 20, 2026 | Tax withholding | −3,412 | $14.34 | $48.93K | 75,322 |
| Uri Geiger Director | Dec 19, 2025 | Award | +715 | $16.59 | $11.86K | 13,945 |
| Rakhi Kumar Director | Dec 19, 2025 | Award | +904 | $16.59 | $15.00K | 18,007 |
| Frank M. Fischer Director | Dec 19, 2025 | Award | +1,431 | $16.59 | $23.74K | 593,351 |
| Joseph Lacob Director | Dec 19, 2025 | Award | +678 | $16.59 | $11.25K | 13,889 |
| Martha Morrell CHIEF MEDICAL OFFICER | Dec 15, 2025 | Sale(10b5-1 plan) | −25,000 | $15.97 | $399.25K | 49,964 |
| Martha Morrell CHIEF MEDICAL OFFICER | Dec 3, 2025 | Tax withholding | −1,338 | $16.66 | $22.29K | 78,734 |
| Martha Morrell CHIEF MEDICAL OFFICER | Nov 27, 2025 | Tax withholding | −357 | $16.50 | $5.89K | 80,072 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Nov 27, 2025 | Tax withholding | −1,126 | $16.50 | $18.58K | 103,086 |
| Martha Morrell CHIEF MEDICAL OFFICER | Nov 20, 2025 | Tax withholding | −3,051 | $13.50 | $41.19K | 80,429 |
| Frank M. Fischer Director | Sep 19, 2025 | Award | +2,389 | $9.94 | $23.75K | 591,920 |
| Joseph Lacob Director | Sep 19, 2025 | Award | +1,131 | $9.94 | $11.24K | 13,211 |
| Rakhi Kumar Director | Sep 19, 2025 | Award | +1,509 | $9.94 | $15.00K | 17,103 |
| Uri Geiger Director | Sep 19, 2025 | Award | +1,194 | $9.94 | $11.87K | 13,230 |
| Martha Morrell CHIEF MEDICAL OFFICER | Sep 3, 2025 | Tax withholding | −1,337 | $9.36 | $12.51K | 83,480 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Aug 27, 2025 | Tax withholding | −1,126 | $8.88 | $10.00K | 104,212 |
| Martha Morrell CHIEF MEDICAL OFFICER | Aug 27, 2025 | Tax withholding | −357 | $8.88 | $3.17K | 84,817 |
| Martha Morrell CHIEF MEDICAL OFFICER | Aug 20, 2025 | Tax withholding | −3,052 | $8.66 | $26.43K | 85,174 |
| Uri Geiger Director | Jun 21, 2025 | Award | +1,140 | $10.41 | $11.87K | 12,036 |
| Joseph Lacob Director | Jun 21, 2025 | Award | +1,080 | $10.41 | $11.24K | 12,080 |
| Frank M. Fischer Director | Jun 21, 2025 | Award | +2,281 | $10.41 | $23.75K | 589,531 |
| Rakhi Kumar Director | Jun 21, 2025 | Award | +1,440 | $10.41 | $14.99K | 15,594 |
| Patrick F. Williams Chief Financial Officer | Jun 20, 2025 | Award | +51,850 | – | – | 51,850 |
| Martha Morrell CHIEF MEDICAL OFFICER | Jun 3, 2025 | Tax withholding | −1,338 | $13.54 | $18.12K | 85,943 |
| Rebecca Kuhn CHIEF FINANCIAL OFFICER | Jun 3, 2025 | Tax withholding | −1,337 | $13.54 | $18.10K | 131,613 |
| Martha Morrell CHIEF MEDICAL OFFICER | May 27, 2025 | Tax withholding | −357 | $12.66 | $4.52K | 87,281 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | May 27, 2025 | Tax withholding | −1,126 | $12.66 | $14.26K | 105,338 |
| Rebecca Kuhn CHIEF FINANCIAL OFFICER | May 27, 2025 | Tax withholding | −357 | $12.66 | $4.52K | 132,950 |
| Rebecca Kuhn CHIEF FINANCIAL OFFICER | May 20, 2025 | Tax withholding | −3,051 | $17.99 | $54.89K | 133,307 |
| Martha Morrell CHIEF MEDICAL OFFICER | May 20, 2025 | Tax withholding | −3,051 | $17.99 | $54.89K | 87,638 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| J. Morrell Martha Officer | Dec 15, 2025 | 25,000 | $404.75K | Dec 15, 2025 | Restricted Stock Units |
| J. Morrell Martha Officer | Jan 30, 2025 | 78,534 | $1.15M | Jan 30, 2025 | Employee Stock Purchase Plan |
| J. Morrell Martha Officer | Jan 29, 2025 | 100 | $1.41K | Jan 29, 2025 | Employee Stock Purchase Plan |
| J. Morrell Martha Officer | Jan 24, 2025 | 3,200 | $44.86K | Jan 24, 2025 | Employee Stock Purchase Plan |
| Ltd. Kck 10% Stockholder | Oct 28, 2024 | 223,991 | $1.22M | Oct 25, 2024 | Automatic Conversion of Preferred Stock at Issuer's IPO |
| Ltd. Kck 10% Stockholder | Oct 3, 2024 | 190,000 | $1.47M | Aug 30, 2024 | Automatic Conversion of Preferred Stock at Issuer's IPO |
| Ridley Irina Chief Legal Officer | Mar 15, 2024 | 3,936 | $53.63K | Mar 15, 2024 | ESPP |
| Morrell Martha Chief Medical Officer | Dec 20, 2023 | 48,397 | $483.49K | Dec 20, 2023 | Stock Option Exercise |
| Morrell Martha Affiliate | Dec 6, 2023 | 11,005 | $89.77K | Dec 6, 2023 | ESPP |
| Ltd. KCK Shareholder | Nov 29, 2023 | 262,836 | $2.30M | Nov 27, 2023 | Automatic Conversion of Preferred Stock at Issuer's IPO |
| OrbiMed Private Investments VI, LP Shareholder | Oct 2, 2023 | 288,100 | $2.56M | Oct 2, 2023 | IPO |